MedPath

Phase III Clinical Study on Taste Disorder by Z-103 -Double Blind Comparison Study on Patients with Zinc -deficient and Idiopathic Taste Disorders

Phase 3
Conditions
Zinc-deficient and idiopathic taste disorders
Registration Number
JPRN-jRCT2080220228
Lead Sponsor
ZERIA Pharmaceutical Co.,Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
150
Inclusion Criteria

Inclusion criteria
Patients who do not fall in any of the Exclusion Criteria concerning Diagnosis and are diagnosed to be suffering from zinc-deficient and idiopathic taste disorders.

Exclusion Criteria concerning Diagnosis
1) Drug induced taste disorder
2) Systemic disorder induced taste disorder
3) Psychogenic taste disorder
4) Taste disorder due to disorders of the oral cavity and salivary gland
5) Taste disorder due to disorders of the peripheral nerves
6) Taste disorder due to central nerve disorders
7) Taste disorder due to genetic disorders
8) Disorders of the olfactory sense and flavor sensing
9) Other taste disorder for which medically clear causes (excluding zinc deficiency) are recognized
others

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath